Brainstorm Cell Therapeut... (BCLI)
0.76
-0.02 (-2.07%)
At close: Apr 15, 2025, 3:56 PM
0.77
1.90%
After-hours: Apr 15, 2025, 07:25 PM EDT
Brainstorm Cell Therapeutics Stock Forecast
Stock Price Forecast
The 1 analysts with 12-month price forecasts for BCLI stock have an median target of 30, with a low estimate of 30 and a high estimate of 30. The median target predicts an increase of 3847.37% from the current stock price of 0.76.
Latest Analyst Insight Report
According to 1 stock analyst, the rating for Brainstorm Cell Therapeutics Inc. is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.
Financial Forecast this Year
Revenue This Year
20M
from 0
Increased by -%
Revenue Next Year
258M
from 20M
Increased by 1.19K%
EPS This Year
-2.1
from -0.4
Increased by -425%
EPS Next Year
-1.52
from -2.1
Increased by 27.6%